$3.57 0.02 (+0.56%)
11/23/2009 3:08 PM

K V Pharmaceutical Company (KV-A)

CAPS Rating: 5 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Results 1 - 2 of 2

Recs

0
Member Avatar airenInDebt (50.21) Submitted: 11/12/2009 2:05:02 PM : Underperform Start Price: $3.23 KV-A Score: -9.71

I don't think that this stock may have a little run based on artificial media hype, but don't believe the company has really that much to offer to create solid stock gains. So they are developing products to save money in manufacturing supplements and drugs and are also marketing generics. Big deal. There's safer and better places to put my money.

Recs

0
Member Avatar stockresearcher6 (< 20) Submitted: 11/12/2009 2:01:35 PM : Underperform Start Price: $3.23 KV-A Score: -9.71

In reading the SEC filings and the FDA citations, this company on a wholesale basis at almost every site they manage has undermaintained equipment, responded inappropriately or not at all to quality concerns, and run their machinery at rates that were higher than equipment capacity. IMHO this can only mean one thing: lack of attention to quality, excellence and ethics at the highest levels. Read the filings and statements. Each filing for why financial statements are not produced have the statement saying the company has doubts whther or not it will continue to be a "going concern:. This statement is one they legaly must make if they are not sure they will be able to keep the company solvent. Not sure how they will with no production to speak of for most of 2009, recalls, and no current for sale production. This is a long shot people...wait to see how the trials go and whether their board of directors changes. BTW, a good way to post industry leading profits for the short term is to do the things the FDA cited them for...

Results 1 - 2 of 2

Featured Broker Partners